Agreement provides MIMEDX with exclusive rights to Turn’s PermaFusion® proprietary antimicrobial intellectual property (IP), accelerating the product development pipeline for wound and surgical ...
BioStem Technologies has agreed to acquire BioTissue Holdings’ surgical and wound care business, expanding the former company’s existing wound care product range in a deal worth up to $40m. BioStem ...
RANCHO SANTA MARGARITA, Calif.--(BUSINESS WIRE)--New clinical evidence demonstrates the value of Applied Medical’s Alexis wound protector/retractor in pancreaticoduodenectomy (PD) procedures, also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results